The regulation of ESR1 appears to be substantially modified by several genetic variants associated with breast cancer susceptibility, and we have analyzed two of the top causal candidates in an upstream enhancer region, each identified in independent study populations and experimental systems [4,7], in a systematic side-by-side comparison. This evidence concerns the gene ESR1 and breast cancer.